Client of a consultant lobbyist
Aurora Cannabis Inc.
- Meetings this Parliament
- 8
- With MPs
- 2
- Since Nov 2021
- 8
- Active registrations
- 1
Most recent reported meeting: Apr 9, 2026.
Lobbying by Aurora Cannabis Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingWho they meet
Since the current Parliament opened.
MPs
- Patrick Weiler Liberal 1
- Blake Richards Conservative 1
Institutions
- House of Commons3
- Health Canada (HC)2
- Veterans Affairs Canada (VAC)1
- Senate of Canada1
- Finance Canada (FIN)1
Registrations in effect
Consultant In effect since Jul 16, 2026
Consultant Sean Webster of Chelsea Strategy Group Inc.
Consultant lobbyists
-
Sean Webster
Former public office holder
Formerly Special Assistant to the Member of Parliament for Etobicoke Centre, House of Commons, Parliament of Canada (1985–1988)
-
Sean Webster
Former public office holder
Formerly Special Assistant to the Member of Parliament for Etobicoke Centre, House of Commons, Parliament of Canada (1985–1988)
Institutions they may lobby: Agriculture and Agri-Food Canada (AAFC), Canada Revenue Agency (CRA), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Intergovernmental Affairs Secretariat (IGA), Justice Canada (JC), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Safety Canada (PS), Public Services and Procurement Canada (PSPC), Senate of Canada, Veterans Affairs Canada (VAC)
What they're lobbying on (5)Hide details
- Regulations affiliated with Bill C- 45 regarding the legalization of cannabis. Formerly known as Bill C-45: An Act Respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts.
- Governmental policy towards medical cannabis research, product quality standards, medical cost coverage, and displacement of harder and more addictive drugs
- Formerly known as Bill C-45: An Act Respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts. Cannabis Act SC 2018 S16
- Cannabis Act; phased implementation of the Act and its impact on medical patients; development of regulations for the industry and the resulting tax implications of these regulations.
- Canada's policy regarding the rules governing the legalization of marijuana
Registration 783059-382978-2. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Sean Webster · Consultant
- Tony Dean · Senator, Senate of Canada
Governmental policy towards medical cannabis research, product quality standards, medical cost coverage, and displacement of harder and more addictive drugs Read more
Cannabis Act; phased implementation of the Act and its impact on medical patients; development of regulations for the industry and the resulting tax implications of these regulations.
-
Reported by Sean Webster · Consultant
- Varun Srivatsan · Director of Policy, Finance Canada (FIN)
Cannabis Act; phased implementation of the Act and its impact on medical patients; development of regulations for the industry and the resulting tax implications of these regulations. Read more
Governmental policy towards medical cannabis research, product quality standards, medical cost coverage, and displacement of harder and more addictive drugs
-
Reported by Sean Webster · Consultant
- Michael Hamm · Director of Policy, Veterans Affairs Canada (VAC)
Governmental policy towards medical cannabis research, product quality standards, medical cost coverage, and displacement of harder and more addictive drugs
-
Reported by Sean Webster · Consultant
- John Clare · Director General, Health Canada (HC)
- David Pellmann · Director General, Health Canada (HC)
Governmental policy towards medical cannabis research, product quality standards, medical cost coverage, and displacement of harder and more addictive drugs Read more
Regulations affiliated with Bill C- 45 regarding the legalization of cannabis. Formerly known as Bill C-45: An Act Respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts.
Canada's policy regarding the rules governing the legalization of marijuana
-
Reported by Sean Webster · Consultant
- Blake Richards · Member of Parliament
Regulations affiliated with Bill C- 45 regarding the legalization of cannabis. Formerly known as Bill C-45: An Act Respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts. Read more
Governmental policy towards medical cannabis research, product quality standards, medical cost coverage, and displacement of harder and more addictive drugs
-
Reported by Sean Webster · Consultant
- Cathay Wagantall · Member of Parliament, House of Commons
Cannabis Act; phased implementation of the Act and its impact on medical patients; development of regulations for the industry and the resulting tax implications of these regulations. Read more
Governmental policy towards medical cannabis research, product quality standards, medical cost coverage, and displacement of harder and more addictive drugs
-
Reported by Sean Webster · Consultant
- Patrick Weiler · Member of Parliament
Cannabis Act; phased implementation of the Act and its impact on medical patients; development of regulations for the industry and the resulting tax implications of these regulations. Read more
Governmental policy towards medical cannabis research, product quality standards, medical cost coverage, and displacement of harder and more addictive drugs
-
Reported by Sean Webster · Consultant
- Bryn Savage · Senior Policy Advisor, Health Canada (HC)
Cannabis Act; phased implementation of the Act and its impact on medical patients; development of regulations for the industry and the resulting tax implications of these regulations. Read more
Governmental policy towards medical cannabis research, product quality standards, medical cost coverage, and displacement of harder and more addictive drugs
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.